The neuroprotective effects of non-NMDA antagonists in the cerebellum of the spastic Han Wistar mutant

Developmental Neuroscience

Volumn 21, Issue 1, 1999, Pages 76-86

  Nisim, A A ^a   Hernandez, C M ^a   Cohen, R W ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Cerebellum; CNQX; GYKI 52466; Osmotic pumps; Purkinje cells

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; GLUTAMATE RECEPTOR; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA; BRAIN THIRD VENTRICLE; CELL COUNT; CONTROLLED STUDY; DEATH; HISTOLOGY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIFESPAN; MOTOR ACTIVITY; MUTANT; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARESIS; PRIORITY JOURNAL; PURKINJE CELL; RAT;

EID: 0033035280     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017369     Document Type: Article

References (52)

1. Babb TL, Brown WJ (1986): Neuronal, dendritic, and vascular profiles of human temporal lobe epilepsy correlated with cellular physiology in vivo. Adv Neurol 44:949-966.
2. Benveniste H, Drejer J, Schousboe A, Diemer NH (1984): Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43:1369-1374.
3. Bradford HF (1995): Glutamate, GABA and epilepsy. Prog Neurobiol 47:477-511.
4. Brorson JR, Bleakman D, Chard PS, Miller RJ (1992): Calcium directly permeates kainate/ α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in cultured cerebellar Purkinje neurons. Mol Pharmacol 41:603-608.
5. Brunson KL, Khanna A, Martinez A, Cohen RW (1996): The neuroprotective effects of NMDA antagonists in the spastic Han Wistar mutant. Soc Neurosci Abstr 22:1276.
6. Brusa R, Zimmermann F, Koh D-S, Feldmeyer D, Gass P, Seeburg PH, Sprengel R (1995): Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 270:1677-1680.
7. Chapman AG, Al-Zubaidy Z, Meldrum BS (1993): Aniracelam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice. Eur J Pharmacol 231:301-303.
8. Choi DW (1987): Ionic dependence of glutamate neurotoxicity. J Neurosci 7:369-379.
9. Choi DW (1988a): Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
10. Choi DW (1988b): Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends Neurosci 11: 465-469.
11. Choi DW (1995): Calcium: Still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 18:58-60.
12. Cohen RW, Cepeda C, Miyashiro-Turman JE, Levine MS (1997): Development of morphological and physiological alterations in the hippocampus of the spastic Han-Wistar rat. Dev Brain Dysfunct 10:1-14.
13. Cohen RW, Fisher RS, Duong T, Handley VW, Campagnoni AT, Hull CD, Buchwald NA, Levine MS (1991): Altered excitatory amino acid function and morphology of the cerebellum of the spastic Han-Wistar rat. Mol Brain Res 11: 27-36.
14. Donevan SD, Rogawski MA (1993): GYKI 52466, a 2,3-benzodiazepine, is a highly selective, non-competitive antagonist of AMPA/kainatc receptor responses. Neuron 10:51-59.
15. Feasey-Truger KJ, Kargl L. Ten Bruggencate G (1993): Differential effects of dentate kindling on working and reference spatial memory in the rat. Neurosci Lett 151:25-28.
16. Feldman RS, Meyer JS, Quenzer LF (1997): Principles of Neuropsychopharmacology. Sunderland, Sinauer.
17. Gill R (1994): The pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia. Cerebrovasc Brain Metab Rev 6:225-256.
18. 2+: Toxicity is blocked by the N-methyl D-aspartate antagonist MK-801. Proc Natl Acad Sci USA 85:6556-6560.
19. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252:851-853.
20. Honore T, Davies SN, Drejer J, Fletcher EJ, Jacobsen P, Lodge D, Nielsen FE(1988): Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonists. Science 241: 701-703.
21. Honore T, Davies SN, Drejer J, Fletcher EJ, Jacobsen P, Lodge D, Nielsen FE (1987): Potent and competitive antagonism at non-NMDA receptors by FG 9041 and FG 9065. Soc Neurosci Abstr 13:383.
22. Iino M, Ozawa S, Tsuzuki K (1990): Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones. J Physiol (Lond) 424:151-165.
23. Jakoi ER, Sombati S, Gerwin C, DeLorenzo RJ (1992): Excitatory amino acid receptor activation produces a selective and long-lasting modulation of gene expression in hippocampal neurons. Brain Res 582:282-290.
24. Jonas P, Brunashev N (1995): Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels. Neuron 15:987-990.
25. Kemp JA, Foster AC, Wong EHF (1987): Non-competitive antagonists of excitatory amino acid receptors. Trends Neurosci 10:294-298.
26. Le Peillet E, Arvin B, Moncada C, Meldrum BS (1992): The non-NMDA antagonists NBQX and GYKI 52466 protect against cortical and striatal cell loss following transient global ischaemia in the rat. Brain Res 571:115-120.
27. Lester RAJ, Quarum ML, Parker JD, Weber E, Jahr CE (1989): Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the n-methyl-d-aspartate receptor-associated glycine binding site. Mol Pharmacol 35:565-570.
28. Levine MS, Cohen RW, Duong T, Fisher RS, Watson JB, Campagnoni AT, Margulies JE, Buchwald NA (1992): The spastic Han-Wistar rat: A genetic model of amino acid-induced excitotoxicity. Brain Dysfunct 5:106-120.
29. Marti A, Salles KS, Grassi S, Abood LG (1986); Behavior and receptor changes after kainate lesioning of nodular cerebellum. Pharmacol Biochem Behav 25:589-594.
30. Margulies JE, Cohen RW, Levine MS, Watson JB (1993): Decreased GluR2(B) receptor subunit mRNA expression in cerebellar neurons at risk for degeneration. Dev Neurosci 15:110-120.
31. Mayer ML, Westbrook GL (1987): The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol 28:197-276.
32. Mody I (1993): The molecular basis of kindling. Brain Pathol 3:395-403.
33. 2+ in cell killing. Chem Res Toxicol 3: 484-494.
34. 3H]α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites. J Neurochem 54:686-695.
35. Olney JW, Collins RC, Sloviter RS (1986a): Excitotoxic mechanisms of epileptic brain damage. Adv Neurol 44:857-877.
36. Olney JW, Price MT, Samson L, Labruyere J (1986b): The role of specific ions in glutamate neurotoxicity. Neurosci Lett 65:65-71.
37. Ouardouz M, Durand J (1991): GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motor neurones. Neurosci Lett 125:5-8.
38. 2+-permeable AMPA receptors in neurological disorders. Trends Neurosci 20: 464-470.
39. Pittermann W, Sontag K-H, Wand P, Rapp K, Deerberg F (1976): Spontaneous occurrence of spastic paresis in Han Wistar rats. Neurosci Lett 2:45-49.
40. Pollard H, Cantagrel S, Charriaut-Marlangue C, Moreau J, Ben Ari Y (1994): Apoptosis associated DNA fragmentation in epileptic brain damage. Neuroreport 5:1053-1055.
41. Rothman SM (1985): The neurotoxicity of excitatory amino acids is produced by passive chloride influx. J Neurosci 5:1483-1489.
42. Rothman SM, Thurston JH, Hauhart RE (1987): Delayed neurotoxicity of excitatory amino acids in vitro. Neuroscience 22:471-480.
43. Siman R, Noszek JC, Kegerise C (1989): Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage, J Neurosci 9:1579-1590.
44. Smith SE, Durmuller N, Meldrum BS (1991): The non-n-methyl-d-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur J Pharmacol 20:179-183.
45. Smith SE, Meldrum BS (1992): Cerebroprotective effect of a non-n-methyl-d-aspartate antagonist. GYKI 52466, after focal ischemia in the rat. Stroke 23:861-864.
46. Sokal RR, Rohlf FJ (1981): Biometry, ed 2. San Francisco, Freeman.
47. Sommer B, Kohler M, Sprengel R, Seeburg PH (1991): RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67:11-19.
48. Strasser U, Fischer G (1995): Protection from neuronal damage induced by combined oxygen and glucose deprivation in organotypic hippocampal cultures by glutamate receptor antagonists. Brain Res 687:167-174.
49. Tarnawa I, Molnar P, Gaal L, Andrasi F (1992): Inhibition of hippocampal field potentials by GYKI 52466 in vitro and in vivo. Acta Physiol Hung 79:163-169.
50. Verdoorn TA, Burnashev N, Monyer H, Seeburg PH, Sakmann B (1991): Structural determinants of ion flow through recombinant glutamate receptor channels. Science 252:1715-1718.
51. Wagemann E, Schmidt-Kastner R, Block F, Sontag K-H (1991): Neuronal degeneration in the hippocampus and cerebellum of mutant spastic Han-Wistar rats. Neurosci Lett 121:102-106.
52. Watkins JC, Olverman HJ (1987): Agonists and antagonists for excitatory amino acid receptors. Trends Neurosci 10:265-272.